Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma
Clinical trial NCT01335009 · COMPLETED
Trial details
- NCT number
- NCT01335009
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-16
- Primary completion
- 2013-12-02
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.